advertisement

Topcon

Journal of Ocular Pharmacology and Therapeutics 8

Showing records 1 to 8 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

52984 Central corneal thickness and glaucoma treatment: an italian multicenter cross-sectional study
Iester M; Telani S; Brusini P; Rolle T; Fogagnolo P; Martini E; Milano G; Paoli And The Italian Glaucoma Register D
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 469-473
52379 Effects of Dorzolamide-Timolol and Brimonidine-Timolol on Retinal Vascular Autoregulation and Ocular Perfusion Pressure in Primary Open Angle Glaucoma
Feke GT; Rhee DJ; Turalba AV; Pasquale LR
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 639-645
53006 A comparison between the fluocinolone acetonide (retisert) and dexamethasone (ozurdex) intravitreal implants in uveitis
Arcinue CA; Cerón OM; Foster CS
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 501-507
52414 Secondary Glaucoma After Intravitreal Dexamethasone 0.7 mg Implant in Patients with Retinal Vein Occlusion: A one-Year Follow-Up
Meyer LM; Schönfeld CL
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 560-565
52978 Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors
Guedes GB; Karan A; Mayer HR; Shields MB
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 456-461
52857 Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%
Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 290-297
52417 Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits
Jessen BA; Shiue MH; Kaur H; Miller P; Leedle R; Guo H; Evans M
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 574-585
52464 Bevacizumab-Loaded Polyurethane Subconjunctival Implants: Effects on Experimental Glaucoma Filtration Surgery
Paula JS; Ribeiro VR; Chahud F; Cannellini R; Monteiro TC; Gomes EC; Reinach PS; Rodrigues MD; Cunha AS
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 566-573

Issue 15-1

Change Issue


advertisement

Oculus